Altimmune Outlines Pemvidutide Plans In MASH And Beyond

 
• By Joseph Haas
  
Liver care
Altimmune will study its MASH candidate in alcohol-related liver disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Therapy Areas